Juillet 2019

Because the production of biopharmaceutical products and the use of materials from mammalian origin for their manufacture carries a potential risk of presence of virus, viral safety is an essential factor in the manufacture of these products. Viral safety of biologics is an essential requirement for regulatory authorities, and to ensure the safety of the drug, inactivation and virus removal methods are required for production.